Marcial: Allergan: A Lift from More Than Botox?

Almost everybody knows specialty pharma outfit Allergan (AGN) because of its widely popular Botox product. Botox, originally approved for eye disorders, grew into a blockbuster product as a facial cosmetic agent designed to smooth away wrinkles. But there is more to Allergan, of course, and its efforts to expand its beauty and medical franchise are making its stock pretty attractive, too.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.